Physician

Abdala Sirajeldin, M.D.

According to 2025 Medicare claims, Abdala Sirajeldin, M.D. (NPI: 1649634262) practices ophthalmology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MEI OPERATIONS, PLLC (NPI: 1316008774; TIN: 382992289) and primary practice location at 48532-3425. Sirajeldin is affiliated with the Genesys PHO, L.L.C. (ACO ID: A2597), participating under the MSSP model.

Sirajeldin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 642 traditional Medicare patients, billed 1,955 HCPCS/CPT codes, and received $177,867 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,546 prescription claims across 500 beneficiaries totaling $124,251 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 13 records totaling $447. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $831 to $124,251. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$89K$178K2022 Medicare payment: $82,169 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $154,072 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $177,867 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20224241,161$82,169
20235481,786$154,072
20246421,955$177,867

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$62K$124K2016 Drug cost: $831 (USD; Tot_Drug_Cst)2017 Drug cost: $949 (USD; Tot_Drug_Cst)2018 Drug cost: $22,169 (USD; Tot_Drug_Cst)2019 Drug cost: $87,497 (USD; Tot_Drug_Cst)2020 Drug cost: $31,607 (USD; Tot_Drug_Cst)2021 Drug cost: $62,124 (USD; Tot_Drug_Cst)2022 Drug cost: $51,425 (USD; Tot_Drug_Cst)2023 Drug cost: $70,754 (USD; Tot_Drug_Cst)2024 Drug cost: $124,251 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R13$831
2017N/R43$949
2018194283$22,169
20193261,008$87,497
2020162394$31,607
2021352980$62,124
2022314734$51,425
20234181,123$70,754
20245001,546$124,251

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more222331$89
92014Established patient complete exam of visual system249276$77
92083Exam of visual field with extended testing129150$42
92136Measurement of corneal curvature and depth of eye135135$27
92133Imaging of optic nerve131134$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine181,080$21,172
LumiganBimatoprost271,520$12,699
CyclosporineCyclosporine261,335$9,718
LatanoprostLatanoprost48232,406$9,415
VyzultaLatanoprostene Bunod12594$7,761

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$447Johnson & Johnson Surgical Vision, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdala Sirajeldin, M.D.?

Tedicare shows public-source Medicare data for Abdala Sirajeldin, M.D. (NPI 1649634262), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdala Sirajeldin, M.D. have ACO affiliation data?

Abdala Sirajeldin, M.D. is shown with ACO affiliation data for Genesys PHO, L.L.C. (MSSP, ACO ID A2597).

What billing organization is linked to Abdala Sirajeldin, M.D.?

Abdala Sirajeldin, M.D. is linked to MEI OPERATIONS, PLLC (billing NPI 1316008774) in the available physician profile data.

Does Abdala Sirajeldin, M.D. have Open Payments data?

Abdala Sirajeldin, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.